Literature DB >> 28063743

Hepatobiliary Neoplasia.

Laura E Selmic1.   

Abstract

Older companion animals may be uncommonly affected with hepatobiliary neoplasia. If clinical signs are shown they are often nonspecific. Animals may have increased liver enzyme activities detected on serum biochemistry. Ultrasound imaging can help to characterize liver lesions and guide sampling with fine needle aspiration. Treatment for massive liver tumor morphology involves liver lobectomy. Prognosis depends on the tumor morphology, type, and stage, but can be good for cats and dogs with massive hepatocellular tumors, with animals experiencing prolonged survival and low recurrence rates.
Copyright © 2016 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Biliary; Cat; Dog; Hepatic; Hepatobiliary; Liver; Neoplasia

Mesh:

Year:  2017        PMID: 28063743     DOI: 10.1016/j.cvsm.2016.11.016

Source DB:  PubMed          Journal:  Vet Clin North Am Small Anim Pract        ISSN: 0195-5616            Impact factor:   2.093


  6 in total

1.  Feline hepatobiliary neoplasia and mistaken age.

Authors:  Kathryn M Hotke
Journal:  Can Vet J       Date:  2018-05       Impact factor: 1.008

2.  Influence of hepatic neoplasia on life expectancy in dogs.

Authors:  I F Vilkovyskiy; Yu A Vatnikov; E V Kulikov; E D Sotnikova; S A Yagnikov; S B Seleznev; E A Krotova; V M Byakhova; V N Grishin; V P Avdotin
Journal:  Vet World       Date:  2020-03-04

3.  Risk factors and outcome in dogs with recurrent massive hepatocellular carcinoma: A Veterinary Society of Surgical Oncology case-control study.

Authors:  Janis M Lapsley; Vincent Wavreille; Sabrina Barry; Josephine A Dornbusch; Carolyn Chen; Haley Leeper; Judith Bertran; Diane Scavelli; Julius M Liptak; Chris Wood; Shelly Shamir; Claire Rosenbaum; Vincenzo Montinaro; Brandan Wustefeld-Janssens; Allyson Sterman; Colin Chik; Ameet Singh; Josh Collins; Laura E Selmic
Journal:  Vet Comp Oncol       Date:  2022-05-15       Impact factor: 2.385

4.  Serum steroid profiling of hepatocellular carcinoma associated with hyperadrenocorticism in dogs: A preliminary study.

Authors:  Thandar Oo; Noboru Sasaki; Yoshinori Ikenaka; Takahiro Ichise; Noriyuki Nagata; Nozomu Yokoyama; Kazuyoshi Sasaoka; Keitaro Morishita; Kensuke Nakamura; Mitsuyoshi Takiguchi
Journal:  Front Vet Sci       Date:  2022-09-28

5.  Pharmacokinetic study comparing doxorubicin concentrations after chemoembolization or intravenous administration in dogs with naturally occurring nonresectable hepatic carcinoma.

Authors:  Nina Samuel; Chick Weisse; Allyson C Berent; Cléo P Rogatko; Luke Wittenburg; Kenneth Lamb
Journal:  J Vet Intern Med       Date:  2022-08-16       Impact factor: 3.175

6.  Size of canine hepatocellular carcinoma as an adverse prognostic factor for surgery.

Authors:  Yury Vatnikov; Ilya Vilkovysky; Evgeny Kulikov; Irina Popova; Nadia Khairova; Aleksey Gazin; Andrey Zharov; Darya Lukina
Journal:  J Adv Vet Anim Res       Date:  2020-02-06
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.